These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
747 related articles for article (PubMed ID: 27214046)
1. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate. Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial. Kaeley GS; Evangelisto AM; Nishio MJ; Goss SL; Liu S; Kalabic J; Kupper H J Rheumatol; 2016 Aug; 43(8):1480-9. PubMed ID: 27307526 [TBL] [Abstract][Full Text] [Related]
3. Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate. Kaeley GS; MacCarter DK; Pangan AL; Wang X; Kalabic J; Ranganath VK J Rheumatol; 2018 Dec; 45(12):1628-1635. PubMed ID: 30173153 [TBL] [Abstract][Full Text] [Related]
4. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint. Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908 [TBL] [Abstract][Full Text] [Related]
5. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis. Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937 [TBL] [Abstract][Full Text] [Related]
6. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289 [TBL] [Abstract][Full Text] [Related]
7. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.]. Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321 [TBL] [Abstract][Full Text] [Related]
8. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Satoh K; Tamai M; Nakamura H; Okada A; Koga T; Yamasaki S; Ida H; Origuchi T; Eguchi K Rheumatology (Oxford); 2011 May; 50(5):962-5. PubMed ID: 21186172 [TBL] [Abstract][Full Text] [Related]
9. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice. Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420 [TBL] [Abstract][Full Text] [Related]
10. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996 [TBL] [Abstract][Full Text] [Related]
11. Ultrasound joint inflammation in rheumatoid arthritis in clinical remission: how many and which joints should be assessed? Naredo E; Valor L; De la Torre I; Martínez-Barrio J; Hinojosa M; Aramburu F; Ovalles-Bonilla JG; Hernández D; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L Arthritis Care Res (Hoboken); 2013 Apr; 65(4):512-7. PubMed ID: 23044729 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints. Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842 [TBL] [Abstract][Full Text] [Related]
13. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission. Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930 [TBL] [Abstract][Full Text] [Related]
14. Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids. Larché MJ; Seymour M; Lim A; Eckersley RJ; Pétavy F; Chiesa F; Rioja I; Lukey PT; Binks M; McClinton C; Dolan K; Taylor PC J Rheumatol; 2010 Dec; 37(12):2493-501. PubMed ID: 20889600 [TBL] [Abstract][Full Text] [Related]
15. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis. Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis. Finzel S; Kraus S; Figueiredo CP; Regensburger A; Kocijan R; Rech J; Schett G Ann Rheum Dis; 2019 Sep; 78(9):1186-1191. PubMed ID: 31142474 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial. Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521 [TBL] [Abstract][Full Text] [Related]
18. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH J Rheumatol; 2009 Jul; 36(7):1429-41. PubMed ID: 19369462 [TBL] [Abstract][Full Text] [Related]
19. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762 [TBL] [Abstract][Full Text] [Related]